HEARTLAND GROUP HOLD

HGH
End-of-day quote. End-of-day quote  - 11/29
2.2NZD -3.08%
Valuation
Fiscal Period: June 2021 2022
Capitalization1 1 2131 298
Entreprise Value (EV)1 1 2131 298
P/E ratio 13,9x13,7x
Yield 5,31%5,49%
Capitalization / Revenue 4,83x4,97x
EV / Revenue 4,83x4,97x
EV / EBITDA --
Price to Book 1,59x1,51x
Nbr of stocks (in thousands) 585 904589 834
Reference price (NZD) 2,072,20
Announcement Date 08/23/2021-
Previous period Next period
1 NZD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: June 2021 2022
Net sales1 251261
EBITDA --
Operating profit (EBIT)1 129134
Operating Margin 51,5%51,2%
Pre-Tax Profit (EBT)1 119131
Net income1 87,094,8
Net margin 34,6%36,3%
EPS2 0,150,16
Dividend per Share2 0,110,12
Announcement Date 08/23/2021-
Previous period Next period
1 NZD in Million
2 NZD
Finances - Leverage
Fiscal Period: June 2021 2022
Net Debt --
Net Cash position --
Leverage (Debt / EBITDA) --
Free Cash Flow --
ROE (Net Profit / Equities) 11,9%11,7%
Shareholders' equity1 731812
ROA (Net Profit / Asset) 2,16%2,69%
Assets1 4 0353 523
Book Value Per Share2 1,301,45
Cash Flow per Share --
Capex --
Capex / Sales --
Announcement Date 08/23/2021-
Previous period Next period
1 NZD in Million
2 NZD
Financial Ratios
Size 2022e 2023e
Capitalization 1 298 M NZD -
Valuation 2022e 2023e
P/E ratio (Price / EPS) 13,7x 12,9x
Capitalization / Revenue 4,97x 4,70x
Yield (DPS / Price) 5,49% 5,87%
Price to book (Price / BVPS) 1,51x 1,41x
Profitability 2022e 2023e
Operating Margin (EBIT / Sales) 51,2% 51,7%
Operating Leverage (Delta EBIT / Delta Sales) 0,83x 1,18x
Net Margin (Net Profit / Revenue) 36,3% 36,8%
ROA (Net Profit / Asset) 2,69% 2,75%
ROE (Net Profit / Equities) 11,7% 11,5%
Rate of Dividend 75,2% 75,7%
Balance Sheet Analysis 2022e 2023e
CAPEX / Sales   0 0
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) 13,5x 13,4x
Financial Leverage (Net Debt / EBITDA) - -
Price Earning Ratio
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS & Dividend